NCT06936735View on ClinicalTrials.gov

Phase I Study of HS-20108 in Participants With Advanced Solid Tumors

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

502

Participants

Timeline

Start Date

April 17, 2025

Primary Completion Date

October 28, 2027

Study Completion Date

November 27, 2027

Conditions

Advanced Solid Tumor

Interventions

DRUG

HS-20108 Monotherapy

Intravenous (IV) Infusion

Trial Locations (1)

130000

Jilin Cancer Hospital, Jilin

All Listed Sponsors

lead

Hansoh BioMedical R&D Company

INDUSTRY